EDITOR BOARD MEMBERS : VIEW ALL
Dr Bikasih Thapa & Dr Maheswar Prasad (Nepal) - Hideo Wada MD PhD (japan) - Dr a Lavra Castrocatesana (Mexico) - Dr Mrs N.M. Hettiarachechui (Srilanka) - Dr Jorge Aldrete Velasco (Mexico) - Prof Hans Peter Kohler (Switzerland) - Dr Hermanus Suhartono S Sp.OG(K) PhD - Dr Isabel Pinheiro (Portugal) - Dr Suranga (Srilanka) - Jovia Dino Jansen Amsterdam,Holand - Hideo Wada MD PhD University Graduate School of Medicine Departement of Moleculer and Laboratory Medicine Japan - DR Bikash Thapa Internal Medicine Nepal University - DR Maheswar Prasad Internal Medicine Nepal University - Dr a Lavra Castro Castresana Colegio de Medicina interna de Mexico - Dr Suransa Manilgama University of Srilanka Internal Departement Medicine - Dr Mrs N.M. Hettiarachechui University of Medicine Srilanka - Dr Jorge Aldrete Velaso .Colegio de Medicina Interna de Mexico - Prof Hans Peter Kholer M.D FACD Profesor of Medicine University ot Switzerland - Dr Ramezan Ali Atace . Baqiyatallah University of Medical Sciences Departement of Micrology Tehran Iran - Ezekiel Wong Toh Yoon Dr. Gastroenterology of Japan - D Eric Beck,MD Bethesda Hospital Capitol Boelevard St Paul USA - Dr Emine Guderen Sahin Istambul University of Internal Medicine Turky - Dr Selmin Toplan Istambul University - Dr Nicholas New Australia - Dr Kughan Govinden. Tropical Infection of Internal Medicine Malaysia - Dr Godfrey M Rwegerera Princes Marina Hospital Bostwana -
A NEW HOPE: A NEW TREATMENT PATTERN OF VARIOUS DISEASES BASED ON ABO BLOOD TYPES

Author : Arend L. Mapanawang

Abstract

The treatment pattern of various diseases is still oriented toward approach to body weight and dosage in milligrams, or mg/ kgw. Various problems arise, such as side effects, toxicity, and drug resistance. It is recognized that the entry of the drug into the body can be affected by several factors such as genes, race, gender, age, and weight. These factors are closely linked to the pharmacokinetics of drugs that include absorption, distribution, metabolism, and elimination stages (ADME). 1 Research on genes and the ABO blood group shows that there are differences in the pharmacokinetics of each type of medication with each blood type.2 The treatment approach based on ABO blood type can increase the effectiveness of therapy and reduce side effects, toxic effects, and resistance on each individual. Currently, the treatment pattern generally provides the same dose to all blood types. In that regards, various diets based on blood types have also been developed. In the future, research should be developed towards the field of biomolecular, genes, and ABO blood group so that the pattern of disease treatment can target appropriate organ, with appropriate dosage, and with minimum side effects, toxicity and resistance, so that each individual receiving treatment is actually healing and safe from the adverse effects of the drug.

[ PDF ]

 

Indexing

;;;;;;;;

 

PENGUNJUNG KAMI DARI BERBAGAI BELAHAN DUNIA

Flag Counter